ERAS on Postoperative Recovery After Laparoscopic Distal Gastrectomy
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Dec 5, 2022
Trial Information
Current as of January 17, 2025
Completed
Keywords
ClinConnect Summary
Adult patients undergoing elective laparoscopic distal gastrectomy are randomly allocated to receive the ERAS protocol (n=49) or conventional protocol (n=49). The conventional groups receive our current perioperative management. The ERAS groups receive our new ERAS protocol including preoperative carbohydrate loading, shortening of perioperative fasting time, and multimodal opioid-sparing analgesia. The primary outcome measure was the postoperative quality of recovery evaluated using the Korean version of Quality of recovery-15 at 24, 48, and 72 hours postoperatively. The secondary outcome ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled to undergo elective laparoscopic distal gastrectomy
- • American Society of Anesthesiologists (ASA)physical classification I-II
- • ECOG Performance Status Scale 0 or 1
- • Willingness and ability to sign an informed consent document
- Exclusion Criteria:
- • Patients with chronic pain
- • Gastrectomy with combined resection of other organs
- • Patients with history of upper abdominal surgery
- • Allergies to anesthetic or analgesic medications (fentanyl, ropivacaine, acetaminophen, NSAIDs)
- • Medical or psychological disease that can affect the treatment response
Trial Officials
Do Joong Park, MD, PhD
Study Director
Seoul National University Hospital
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seoul, Seoul Teugbyeolsi, Korea, Republic Of
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials